Akero Therapeutics Inc
Biotechnology
Healthcare
AKRO
69.44 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
33.20
52 week high
57.56
high
38.12
52 week low
21.45
previous Close
34.04
P/E ratio
-36
market cap
1.98 B
div yield
0
net incoming
-72.71 M
-29.86 %
net profit margin
-7270500000.00 %
0.00 %
operating incoming
-81.70 M
-24.28 %
net change in cash
5.71 M
101.82 %
cash on hand
316 M
1.84 %
top